Multi-year funding will advance oral health, as oral diseases are among the most prevalent and overlooked noncommunicable diseases impacting 3.7 billion people globally. 1
Chevron, Colgate-Palmolive, and Merck highlight how dividends, durable businesses, and long-term growth drivers can support a buy-and-hold investment strategy
Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2025 fourth quarter and full year earnings conference call on Friday, January 30, 2026, at 8:30 a.m. ET. The call will be hosted by...
Household Products Stocks Q3 Teardown: Colgate-Palmolive (NYSE:CL) Vs The Rest
Colgate-Palmolive is set to report its fourth-quarter results soon, and analysts predict a single-digit rise in the company’s bottom-line figure.
2 Reasons to Like CL and 1 to Stay Skeptical
Colgate-Palmolive is a good buy-and-hold stock for 2026, as it is on the cusp of a significant market reversal linked to value and capital returns.
2 Cash-Producing Stocks Worth Investigating and 1 We Question
The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today declared a quarterly cash dividend of $0.52 per common share, payable on February 13, 2026, to shareholders of record on January 21,...
2 Safe-and-Steady Stocks with Competitive Advantages and 1 We Find Risky